A new gene therapy shrank the tumors of a woman with pancreatic cancer. Researchers think it has the potential to benefit millions more.
An experimental treatment appears to have been successful in halting the progression of one woman's advanced pancreatic cancer, doctors reported Wednesday in theThe apparent success of the therapy — which involves tweaking the genes of immune cells so that they attack tumor cells — could be a major step forward in the treatment of not only“I’m really excited about this,” said Dr. Carl June, who more than a decade ago pioneered a different type of immune therapy for certain blood cancers.
With that in mind, she reached out to the author of the report, Eric Tran. Tran was at the National Institutes of Health when he treated the colon cancer patient, but had since moved on to the Providence Cancer Institute in Portland, Oregon. That’s where Wilkes found him and inquired about undergoing the same type of therapy.
“This is potentially a one-and-done treatment,” Dr. Rom Leidner, a co-author of the new report and co-director of the head and neck cancer therapy program at the Providence Cancer Institute, said of the new therapy.Wilkes' infusion was on June 14, 2021. Within a month, the tumors in her lungs shrank by more than half, the report found. Six months later, the tumors were reduced by 72 percent of their original size.
Another patient with pancreatic cancer who received the same treatment at the Providence Cancer Institute did not survive. It's unclear why the treatment seems to have been successful in one person but failed in another. “This particular mutation is common in tumors that arise from epithelial cells, such as lung, ovarian and pancreatic cancers," Rubin said during a media briefing Wednesday. “We for the first time have an approach that could allow the treatment of a large variety of tumors beyond the small number of tumors that CAR-T cells can be used in a very specific type of immunotherapy.”
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Will gene therapy comeback last? Scientists try to make it saferUnwanted immune responses threaten to derail some gene therapies. But researchers are seeking ways to combat harmful inflammation.
Les mer »
Mobile Support Group at Chicago Hospital Helps Patients Grow Strong BondsTwo strangers forged a unique friendship in the hallways of a local hospital, with the duo forming a mobile support group as they battled the same form of leukemia.
Les mer »
Wondering what COVID variant you're infected with? Rutgers scientists developed a real-time test for thisScientists hope new tests will be able to identify COVID variants in a broader swath of patients, which could improve public health surveillance and help make better treatment decisions.
Les mer »
A human liver preserved for three days outside of the body was successfully transplantedA patient who received a human liver that was preserved for three days outside of the body using machine perfusion remains healthy after one year.
Les mer »
'Barry' gets intense for Henry Winkler. Here's why that is such a good thing“It’s the most outrageous, intense work I have ever done,' the one-time Fonz says of his role as terrible acting teacher Gene Cousineau.
Les mer »
The Mona Lisa Is Really Having One of Those WeeksBetween a cake-smearing vandal and a visit from the Da Vinki twins, the famous 500-year-old just can't catch a break.
Les mer »